Measuring immune response to COVID-19 in patients with weakened immune systems
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients
['FUNDING_OTHER'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-11191768
This study is looking at a new way to check how well the immune system responds to the COVID-19 virus in people with Multiple Myeloma, a type of blood cancer that can weaken immunity, to help improve their care and treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11191768 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new method to measure the immune response to SARS-CoV-2 in patients with Multiple Myeloma, a type of blood cancer that weakens the immune system. The approach involves using a qPCR-based assay to quantify specific T cells that respond to the virus, which is crucial for understanding how well these patients can fight off infections. By analyzing blood samples from these patients, the study aims to provide insights into their cellular immunity, which is often overlooked in traditional testing methods. This could lead to better monitoring and treatment strategies for immunocompromised individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Multiple Myeloma who are at risk of severe COVID-19 due to their compromised immune systems.
Not a fit: Patients who do not have Multiple Myeloma or other similar immunocompromising conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the ability to monitor and improve immune responses in patients with weakened immune systems, leading to better health outcomes.
How similar studies have performed: Other research has shown promise in using similar qPCR-based methods to assess immune responses, indicating that this approach could be effective.
Where this research is happening
NEW YORK, UNITED STATES
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GUCCIONE, ERNESTO — ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
- Study coordinator: GUCCIONE, ERNESTO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bacterial Infections